Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 15 June, 2018

Euronext Dublin

MSM - Suspension Notice

RNS Number : 4341R
Euronext Dublin
15 June 2018
 

Suspension Notice

 

Euronext Dublin

28 Anglesea Street

Dublin 2

 

 

15th June 2018

 

 

 

Listing and trading of the under-mentioned securities of ARM ASSET-BACKED SECURITIES S.A. have been temporarily suspended, as detailed below.

 

Date and time of the communication

2018-06-15T07:00:00Z

Action type

Suspension of trading and listing

Reasons for the action

Non publication of annual and half yearly financial report as required by Regulation 4(2) and Regulation 6(2) of the Transparency (Directive 2004/109/EC) Regulations 2007

Effective from

2018-06-15T07:00:00Z

Effective to

2018-06-25T07:00:00Z

Ongoing

False

Trading venue(s)

XMSM

Issuer name

ARM ASSET-BACKED SECURITIES S.A.

Issuer Legal Entity Identifier (LEI)


Instrument identifier (ISIN)

XS0382048238

Instrument full name

GBP 2050000 Asset-Backed Income Bond due 2018 - Tranche 3

Sufficiently related derivatives


Other related instruments

XS0382049806, XS0382050994, XS0382094778, XS0382095403, XS0382097102, XS0382098761, XS0382104676, XS0382104759, XS0383742227, XS0383743548, XS0383744512, XS0383745592, XS0385399653, XS0401195663, XS0401196042, XS0401197016, XS0401208078, XS0403839300, XS0403908980, XS0403931701, XS0409505756, XS0409508347, XS0409508420, XS0414829159, XS0414829662, XS0414830249, XS0414850353, XS0414886381, XS0414921394, XS0414931948, XS0414934538, XS0414937390,  XS0414945575, XS0429169948, XS0429170011, XS0432578200, XS0432578895, XS0432579273, XS0432579356, XS0451514847

Comments


 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEGGUGWQUPRGGC

a d v e r t i s e m e n t